Patent Assignment
Reel/Frame 013965/0566
Assignment of Assignor's Interest
Recorded: 2003-04-11
Pages: 32
Assignor
Assignee
ALLERGAN, INC.
2525 DUPONT DRIVE, IRVINE, CALIFORNIA, 92612
Covered Properties
(14)
Non-Acidic Cyclopentane Heptanoic Acid, 2-Cycloalkyl or Arylalkyl Derivatives as Therapeutic Agents
Application:
08/876,937 →
Alkyl or Aryl Substituted Dihydronaphthalene Derivatives Having Retinoid and/or Retinoid Antagonist-Like Biological Activity
Patent:
6,653,483 →
Application:
09/550,952 →
Methods of Identifying Compounds Having Nuclear Receptor Negative Hormone and/or Antagonist Activities
Patent:
6,942,980 →
Application:
09/685,828 →
Cyclopentane Heptan (Ene)Oic Acid, 2-Heteroarylalkenyl Derivatives as Therapeutic Agents
Conformationally Rigid Bicyclic and Adamantane Derivatives Useful as ALPHA2-Adrenergic Blocking Agents
Methods of Treatment with Compounds Having Rar Alpha Receptor Specific or Selective Activity
Alkyl or Aryl Substituted Dihydronaphthalene Derivatives Having Retinoid and/or Retinoid Antagonist-Like Biological Activity
Method and compositions for the treatment of cerebral palsy
Application:
10/155,280 →
Publication:
US 2002/0142010
Substituted Diaryl or Diheteroaryl Methans, Ethers and Amines Having Retinoid Agonist, Antagonist or Inverse Agonist Type Biological Activity
Thromboxane Ligands Without Blood Clotting Side Effects
O- or S-Substituted Tetrahydronaphthalene Derivatives Having Retinoid and/or Retinoid Antagonist-Like Biological Activity
Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
Application:
10/282,726 →
Publication:
US 2003/0114528
Alkyl or Aryl Substituted Dihydronaphthalene Derivatives Having Retinoid and/or Retinoid Antagonist-Like Biological Activity
Aryl Substituted 3,4-Dihydroanthracene Derivatives Having Retinoid Antagonist or Retinoid Inverse Agonist Type Biological Activity
Related Assignments
(1)
Other recorded transfers of the patents in this record — the chain of ownership.